Ali Jaber, Ph.D. MS in Pharmacy MS in Pharmaceutical Chemistry

Size: px
Start display at page:

Download "Ali Jaber, Ph.D. MS in Pharmacy MS in Pharmaceutical Chemistry"

Transcription

1 Nonsteroidal antiinflammatory drugs (NSAID) Ali Jaber, Ph.D. MS in Pharmacy MS in Pharmaceutical Chemistry

2 The inflammatory response occurs in vascularised tissues in response to injury. It is part of the innate nonspecific immune response. Inflammatory responses require activation of leukocytes: neutrophils, eosinophils, basophils,mast cells, monocytes, and lymphocytes,

3 Ex Inflammatory stimulus (+) Phospholipids In Phospholipase A 2 Arachidonic acid Cyclooxy genase (COX) 5-lipoxygenase 15-lipoxygenase Endoperoxides Leucotrienes Lipoxins PGs TxA 2

4 PROSTANOIDS (PGs & Txs) PGI 2 (prostacyclin) is located predominantly in vascular endothelium. Main effects: vasodilatation inhibition of platelet aggregation TxA 2 is found in the platelets. Main effects: platelet aggregation vasoconstriction

5 PGE 2 causes: inhibition of gastric acid secretion contraction of pregnant uterus contraction of GI smooth muscles PGF 2α main effects: contraction of bronchi contraction of miometrium

6 Cyclooxygenase (COX) is found bound to the endoplasmatic reticulum. It exists in 3 isoforms: COX-1 (constitutive) acts in physiological conditions. COX-2 (inducible) is induced in inflammatory cells by pathological stimulus. COX-3 (in brain).

7 Essential of Medical Pharmacology 5 st Ed. (2003)

8 COX inhibitors NSAIDs Nonselective COX-1/COX-2 inhibitors COX-2 inhibitors Selective (coxibs) Preferential COX-3 inhibitors Antipyretic analgesics

9 Nonselective COX-1/COX-2 inhibitors (Classical NSAIDs) Salicylates Phenylacetates Indolacetates Enolates De rivatives Fenamates of acid Propionates Butylpyrazolidindiones Pyrazolones

10 Nonselective COX-1/COX-2 inhibitors Acetylsalicylic acid (Aspirin ) Paracetamol (Panadol) Diclofenac (Voltaren) Indometacin Piroxicam (Brexin) Meloxicam (Mobic) Ibuprofen (Brufen) Ketoprofen (Profenid)

11 Beneficial actions of NSAIDs due to prostanoid synthesis inhibition 1. Analgesia prevention of pain nerve ending sensitization 2. Antipyresis connected with influence of thermoregulatory centre in the hypothalamus 3. Antiinflammatory action mainly antiexudative effect 4. Antithrombotic action in very low daily doses 5. Closure of ductus arteriosus

12 Shared toxicities of NSAIDs due to prostanoid synthesis inhibition 1. Gastric mucosal damage connected with PGE inhibition 2. Bleeding: inhibition of platelet function (TxA 2 synthesis) 3. Limitation of renal blood flow Na + and water retention 4. Delay / prolongation of labour connected with PGF 2α inhibition 5. Asthma and anaphylactoid reactions connected with PGF 2α inhibition

13 Lüllmann, Color Atlas of Pharmacology 2 nd Ed. (2000)

14 Aspirin (Bayer, 1899) As analgesic for headache,pulled muscle, neuralgias. As antipyretic in fever of any origin. However, paracetamol is preferred Acute rheumatic fever. Aspirin is the first drug of choice. Other drugs substitute Aspirin only when it fails or in severe cases. Rheumatoid arthritis. Aspirin a dose of 3 to 5 g/24 h after meal is effective in most cases. Since large doses of Aspirin are poorly tolerated for a long time, the new NSAIDs (diclofenac, ibuprofen, etc.) in depot form are preferred.

15 Aspirin therapy in children with rheumatoid arthritis has been found to raise serum concentration transaminases, indicating liver damage. Most cases are asymptomatic but it is potentially dangerous. An association between salicylate therapy and Reye s syndrome, a rare form of hepatic encephalopathy seen in children, having viral infection (varicella, influenza), has been noted. Aspirin should not be given to children under 15 years unless specifically indicated, e.g. for juvenile arthritis (paracetamol is preferred). Postmyocardial infarction and poststroke patients. By inhibiting platelet aggregation in low doses (100 mg daily) Aspirin decreases the incidence of reinfarction.

16 Arachidonic acid Cyclooxygenase (COX) Endoperoxides (-) >1 g/24 h Aspirin Thromboxane A 2 synthase (-) 100 mg/24 h PGs TxA 2

17 Drug interactions with NSAIDs Drugs Result Diuretics Decrease diuresis Beta-blockers Decrease antihypertensive effect ACE inhibitors Decrease antihypertensive effect Anticoagulants Increase of GI bleeding Sulfonylurea Increase hypoglycemic risk Cyclosporine Increase nephrotoxicity GCS Increase of GI bleeding Alcohol Increase of GI bleeding

18 Ibuprofen (Brufen) Oral ibuprofen is often prescribed in lower doses at which it has analgesic but not antiinflammatory efficacy. A topical cream preparation is absorbed into fascia and muscle. A liquid gel preparation of ibuprofen provides prompt relief in postsurgical dental pain.

19 Ketoprofen (Profenid) The effectiveness of ketoprofen at dosages of mg/d is equivalent to that of other NSAIDs in the treatment of rheumatoid arthritis, osteoarthritis, gout, dysmenorrhea, and other painful conditions. In spite of its dual effect on prostaglandins and leukotrienes, ketoprofen is not superior to other NSAIDs. Its major adverse effects are on the GIT and the CNS.

20 Indometacin Is a potent nonselective COX inhibitor and may also inhibit phospholipase, reduce neutrophil migration, and decrease T cell and B cell proliferation. Indications: juvenile rheumatoid arthritis, gout and post episiotomy pain. Side effects: A high incidence (up to 50%) of GI and CNS side effects is produced: GI bleeding, diarrhoea, frontal headache, mental confusion, etc.

21 Diclofenac (Voltaren) Diclofenac in rectal suppository form can be considered a drug of choice for analgesia and postoperative nausea. It is also available for intramuscular and oral administration Indications: All moderate pain Side effects occur in approximately 20%: GI distress and occult bleeding, gastric ulceration. A preparation combining diclofenac and misoprostol (PGE 1 ) decreases upper GI ulceration but may result in diarrhoea.

22 Piroxicam, (Feldene) Its long half-life permits once-daily dosing. Piroxicam can be used for the usual rheumatic indications. Side effects: Toxicity includes GI symptoms (20% of patients), dizziness, tinnitus, headache, rash. When piroxicam is used in dosages higher than 20 mg/d, an increased incidence of peptic ulcer and bleeding is encountered. This risk is as much as 10 times higher with piroxicam than with other NSAIDs.

23 COX-2 inhibitors (1) Selective COX-2 inhibitors (Coxibs) Celecoxib (celebrex) Etoricoxib (Arcoxia) (2) Preferential COX-2 inhibitors Meloxicam(Mobic) Nimesulide(Aulin)

24 Inhibiting activity rate (COX-2/COX-1) Aspirin Indometacin Meloxicam ,8 Classical NSAIDs (Preferential COX-2 inhibitor)

25 Coxibs are selective COX-2 inhibitors. They exert antiinflammatory, analgesic, and antipyretic action with low ulcerogenic potential. Coxibs can cause infertility. They have prothrombotic cardiovascular risk. The ulcerogenic potential of preferential COX-2 inhibitors Meloxicam (Mobic), and Nimesulide (Aulin ) is significant.

26 Celecoxib (Celebrex)is as effective as other NSAIDs in the treatment of rheumatoid arthritis and osteoarthritis, Side effects: celecoxib may cause rashes. It does not affect platelet aggregation at usual doses.

27 Etoricoxib (Arcoxia) is a second-generation COX-2-selective inhibitor Indications: treatment of the symptoms of osteoarthritis, rheumatoid arthritis and for the relief of acute musculoskeletal pain Etoricoxib has similar efficacy to traditional NSAIDs for osteoarthritis, acute gouty arthritis, and primary dysmenorrhea and has a GI safety profile similar to other coxibs.

28 Meloxicam (Mobic) It has been shown to preferentially inhibit COX-2 over COX-1 It is not as selective as the other coxibs and may be considered preferentially" selective rather than highly selective. Indications: treatment of osteoarthritis and rheumatoid arthritis. Side effects: are similar to those of other NSAIDs.

29 Comparative action between COX-1/COX-2 COX-2 COX inhibitors inhibitors inhibitors 1. Analgesic action (+) (+) (+) 2. Antipyretic action (+) (+) 3. Antiinflammatory action (+) (+) (+) 4. Antiplatelet aggregatory (+) (-) 5. Gastric mucosal damage (+) (+) (+) (+) 6. Renal salt / water retention (+) (+) 7. Delay/prolongation of labor 8. Infertility (+) (+) (-) (+) (+) (+) 9. Ductus arteriosus closure (+)? 10. Aspirin-like asthma 11. Cardiotoxicity (+) (-)? (+) (+)

30 Bextra (Valdecoxib): Pfizer (penalty!) Many severe side effects Infertility (> PGF 2α ) Thrombosis (< PGI 2 ; > TxA 2 )

31 NONOPIOID ANALGESICS (1) Anilides Paracetamol tabl. 500 mg (Acetaminophen USAN) Propacetamol (prodrug) (2) Pyrazolones Metamizole (Analgin tabl. 500 mg) (3) COX-1/COX-2 inhibitors Aspirin, Diclofenac, Ibuprofen, Naproxen etc. (4) COX-2 inhibitors COX-3 inhibitors (antipyretic analgesics) NSAIDs in low doses

32 Pathogenesis of pain Lüllmann, Color Atlas of Pharmacology 2 nd Ed. (2000)

33 Acetaminophen (USAN) (Paracetamol INN) Efferalgan Panadol ParacetaMAX Propacetamol is a prodrug. It converts into paracetamol. Acetylsalicylic acid Aspirin Aspegic lisinate (Metamizole INN) Analgin Proalgin Lüllmann, Color Atlas of Pharmacology 2nd Ed. (2000)

34 Paracetamol (Panadol, Efferelgan) paracetamol lacks antiinflammatory properties. Indications: mild to moderate pain: headache, myalgia,postpartum pain. paracetamol is the preferred drug in children as antipyretic and analgesic Side effects: hepatotoxcity most of all Acute paracetamol poisoning occurs especially in small children who have low hepatic glucuronide conjugating ability. If a large dose (> 150 mg/kg or > 10 g in adult) is taken, serious toxicity can occur. The letal dose is 250 mg/kg

Nonsteroidal Anti inflammatory Drugs (NSAIDs)

Nonsteroidal Anti inflammatory Drugs (NSAIDs) Nonsteroidal Anti inflammatory Drugs (NSAIDs) DRUG ACTING ON CNS (PHARMACOLOGY) Unit 5 (2) The clinical features of inflammation have been recognized since ancient times as swelling, redness, pain, and

More information

NONSTEROIDAL ANTIINFLAMMATORY DRUGS

NONSTEROIDAL ANTIINFLAMMATORY DRUGS Analgesics are drugs that relieve pain without significantly altering consciousness. They relieve pain without affecting its cause. Analgesics Opioid (Narcotic analgesics) Non-opioid (Nonsteroidal antiinflammatory

More information

MUSCULOSKELETAL PHARMACOLOGY. A story of the inflamed

MUSCULOSKELETAL PHARMACOLOGY. A story of the inflamed MUSCULOSKELETAL PHARMACOLOGY A story of the inflamed 1 INFLAMMATION Pathophysiology Inflammation Reaction to tissue injury Caused by release of chemical mediators Leads to a vascular response Fluid and

More information

Non Steroidal Anti-inflammatory Drugs (NSAIDs) Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Non Steroidal Anti-inflammatory Drugs (NSAIDs) Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Non Steroidal Anti-inflammatory Drugs (NSAIDs) Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Inflammation Inflammation is a complex response to cell injury

More information

Acetaminophen and NSAIDS. James Moriarity MD University of Notre Dame

Acetaminophen and NSAIDS. James Moriarity MD University of Notre Dame Acetaminophen and NSAIDS James Moriarity MD University of Notre Dame Lecture Goals Understand the indications for acetaminophen and NSAID use in musculoskeletal medicine Understand the role of Eicosanoids

More information

Anti-inflammatory drugs

Anti-inflammatory drugs Anti-inflammatory drugs 1 Inflammatory process 1. stimulus (cut) 2. Initial local vasoconstriction( blood loss) 3. vasodilation, local immune/inflammatory reaction (heat, redness) 4. swelling and pain

More information

Analgesics. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014

Analgesics. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014 Analgesics Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014 Mar-14 Munir Gharaibeh, MD, PhD, MHPE 2 Feature Comparison of Analgesics Narcotic (Opioids) Nonnarcotic

More information

EICOSANOID METABOLISM

EICOSANOID METABOLISM 1 EICOSANOID METABOLISM EICOSANOIDS C20 polyunsaturated fatty acids e.g. Arachidonic acid Eicosanoids physiologically, pathologically and pharmacologically active compounds PG Prostaglandins TX - Thromboxanes

More information

Non-Steroidal Anti- Inflammatory Drugs. ATPE 410 Chapter 6

Non-Steroidal Anti- Inflammatory Drugs. ATPE 410 Chapter 6 Non-Steroidal Anti- Inflammatory Drugs ATPE 410 Chapter 6 Inflammatory Process A normal, beneficial process that begins immediately after injury to facilitate repair and return the tissue to normal function

More information

ANTI-HYPERLIPIDEMIC AGENTS AND NSAIDS LECTURE 6

ANTI-HYPERLIPIDEMIC AGENTS AND NSAIDS LECTURE 6 ANTI-HYPERLIPIDEMIC AGENTS AND NSAIDS LECTURE 6 HYPERLIPIDEMIA Cholesterol Total cholesterol LDL cholesterol HDL cholesterol men women Triglycerides

More information

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution

More information

Children Enteric coated tablet : 1-3 mg/kg per day in divided doses.

Children Enteric coated tablet : 1-3 mg/kg per day in divided doses. Ultrafen Tablet/SR Tablet/Suppository/Gel Description Ultrafen is a preparation of Diclofenac is a non-steroidal antiinflammatory agent with marked analgesic, anti-inflammatory and antipyretic properties.

More information

Nonsteroidal Anti inflammatory Drugs (NSAIDs)

Nonsteroidal Anti inflammatory Drugs (NSAIDs) Nonsteroidal Anti inflammatory Drugs (NSAIDs) PHL-358-PHARMACOLOGY AND THERAPEUTICS-I Mr.D.Raju,M.phar, Lecturer Analgesic Antipyretic Anti inflammatory (at higher doses) Common Pharmacological Effects

More information

NONSTEROIDAL ANTI- INFLAMMATORY DRUGS

NONSTEROIDAL ANTI- INFLAMMATORY DRUGS NONSTEROIDAL ANTI- INFLAMMATORY DRUGS MRS. M.M. HAS A 3 YR. HX OF PROGRESSIVE RIGHT HIP PAIN. THE PAIN INCREASES WITH WEIGHT BEARING ACTIVITY. PT. HAS BEEN ON ACETAMINOPHEN WITHOUT RELIEF. PERTINENT LABS

More information

AVERTING RISKS ASSOCIATED WITH UTILISING SMALL ANIMAL NSAIDS

AVERTING RISKS ASSOCIATED WITH UTILISING SMALL ANIMAL NSAIDS Vet Times The website for the veterinary profession https://www.vettimes.co.uk AVERTING RISKS ASSOCIATED WITH UTILISING SMALL ANIMAL NSAIDS Author : Catherine F Le Bars Categories : Vets Date : April 6,

More information

Prostaglandins & NSAIDS 2

Prostaglandins & NSAIDS 2 Prostaglandins & NSAIDS 2 รศ. พ.ญ. มาล ยา มโนรถ ภาคว ชาเภส ชว ทยา คณะแพทยศาสตร จ ดประสงค การศ กษา เม อส นส ดการเร ยนการสอน และการศ กษาด วยตนเองเพ มเต ม น กศ กษาสามารถ 1. ทราบถ งชน ดของ NSAIDs 2. ทราบถ

More information

Name: Class: "Pharmacology NSAIDS (2) Lecture

Name: Class: Pharmacology NSAIDS (2) Lecture I Name: Class: "Pharmacology NSAIDS (2) Lecture د. احمد الزهيري Dosage of Aspirin: NSAIDS (2) Optimal analgesic dose or antipyretic dose is less than 0.6 gm orally (commonly used). Large dose will prolong

More information

NSAIDs: Side Effects and Guidelines

NSAIDs: Side Effects and Guidelines NSAIDs: Side Effects and James J Hale FY1 Department of Anaesthetics Introduction The non-steroidal anti-inflammatory drugs (NSAIDs) are a diverse group of drugs that have analgesic, antipyretic and anti-inflammatory

More information

NSAIDS & Drugs in Rheumatoid Arthritis (RA)

NSAIDS & Drugs in Rheumatoid Arthritis (RA) NSAIDS & Drugs in Rheumatoid Arthritis (RA) RA is a chronic progressive inflammation of joint lining with an autoimmune background against synovial membranes that can lead to joint destruction Affects

More information

NON STEROIDAL ANTI INFLAMMATORY NSAID

NON STEROIDAL ANTI INFLAMMATORY NSAID NON STEROIDAL ANTI INFLAMMATORY DRUGS NSAID inflammation Normal, protective response to tissue injury 1-physical trauma 2-noxious chemical 3-microbial agent NSAIDs act by inhibiting the synth. Of prostaglandins

More information

Index. B Biotransformation, 112 Blood pressure, 72, 75 77

Index. B Biotransformation, 112 Blood pressure, 72, 75 77 Index A Acute gout, treatment, 41 Adenomatous polyposis coli (APC), 224 Adenomatous polyp prevention on Vioxx (APPROVe), 250 Ankylosing spondylitis (AS), 40 41 Antiplatelet therapy, 138 Antithrombotic

More information

Name: Class: "Pharmacology NSAIDS (1) Lecture

Name: Class: Pharmacology NSAIDS (1) Lecture I Name: Class: "Pharmacology NSAIDS (1) Lecture د. احمد الزهيري Inflammation is triggered by the release of chemical mediators from injured tissues and migrating cells. The specific mediators vary with

More information

Prostaglandins And Other Biologically Active Lipids

Prostaglandins And Other Biologically Active Lipids Prostaglandins And Other Biologically Active Lipids W. M. Grogan, Ph.D. OBJECTIVES After studying the material of this lecture, the student will: 1. Draw the structure of a prostaglandin, name the fatty

More information

NSAID Use in Post- Myocardial Infarction Patients. Leah Jackson, BScPhm Pharmacy Resident Cardiology Rotation February 28, 2007

NSAID Use in Post- Myocardial Infarction Patients. Leah Jackson, BScPhm Pharmacy Resident Cardiology Rotation February 28, 2007 NSAID Use in Post- Myocardial Infarction Patients Leah Jackson, BScPhm Pharmacy Resident Cardiology Rotation February 28, 2007 Objectives By the end of the presentation, the audience will be able to use

More information

TERICOX. Composition Each film-coated tablet contains 60, 90, or 120 mg of Etoricoxib.

TERICOX. Composition Each film-coated tablet contains 60, 90, or 120 mg of Etoricoxib. TERICOX Composition Each film-coated tablet contains 60, 90, or 120 mg of Etoricoxib. Tablets Action Tericox is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic,

More information

NSAID Use in Post- Myocardial Infarction Patients

NSAID Use in Post- Myocardial Infarction Patients NSAID Use in Post- Myocardial Infarction Patients Leah Jackson, BScPhm Pharmacy Resident Cardiology Rotation February 28, 2007 Objectives By the end of the presentation, the audience will be able to use

More information

NOTOPAIN CAPLETS. Diclofenac Sodium + Paracetamol. Composition. Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg.

NOTOPAIN CAPLETS. Diclofenac Sodium + Paracetamol. Composition. Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg. NOTOPAIN CAPLETS Diclofenac Sodium + Paracetamol Composition Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg Pharmacology Phamacodynamics Diclofenac relieves pain and inflammation

More information

Review Article. Safety Profile of Nonsteroidal Antiflammatory Drugs (NSAID) Safety Profile of NSAID

Review Article. Safety Profile of Nonsteroidal Antiflammatory Drugs (NSAID) Safety Profile of NSAID Safety Profile of Nonsteroidal Antiflammatory Drugs (NSAID) R. Stoilov: University Hospital St Ivan Rilski, Clinic of Rheumatology Contact: Rumen Stoilov, Clinic of Rheumatology, University Hospital St

More information

Celecoxib Powder, Diclofenac Powder, Flurbiprofen Powder, Ibuprofen Powder, Ketoprofen Powder, Meloxicam Powder, Tramadol Powder

Celecoxib Powder, Diclofenac Powder, Flurbiprofen Powder, Ibuprofen Powder, Ketoprofen Powder, Meloxicam Powder, Tramadol Powder Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.26 Subject: Anti-Inflammatory Pain Powders Page: 1 of 5 Last Review Date: December 3, 2015 Anti-Inflammatory

More information

ASPIRIN. Session Two of TIP Assignment

ASPIRIN. Session Two of TIP Assignment ASPIRIN Session Two of TIP Assignment History Behind Aspirin Development 2 Pain relief is something that has been sought after since the ancient Greeks and Egyptians used bark and dried leaves of the poplar

More information

IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure. Molecular Weight

IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure. Molecular Weight Drug Profile of Dicyclomine Generic Name Dicyclomine IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure Molecular Weight 309.48 Molecular formula C 19 H 35 NO 2 Melting

More information

Elements for a Public Summary Overview of disease epidemiology

Elements for a Public Summary Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Acute pain usually responds to medication and should settle in less than three months. Inadequate pain relief may lead to other

More information

Disclosure. Learning Objectives 1/17/2018. Pumping the Breaks in Pain Management: An Update on Cardiovascular Risk with NSAID Use

Disclosure. Learning Objectives 1/17/2018. Pumping the Breaks in Pain Management: An Update on Cardiovascular Risk with NSAID Use Disclosure Pumping the Breaks in Pain Management: An Update on Cardiovascular Risk with Liz Van Dril, PharmD, BCPS PGY2 Ambulatory Care Resident January 17 th, 2018 Dr. Liz Van Dril has no actual or potential

More information

Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX - First Low Dose SoluMatrix Meloxicam for Osteoarthritis Pain

Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX - First Low Dose SoluMatrix Meloxicam for Osteoarthritis Pain Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX - First Low Dose SoluMatrix Meloxicam for Osteoarthritis Pain VIVLODEX Developed to Align with FDA NSAID Recommendations Proven Efficacy at Low

More information

TIVORBEX Now Available in U.S. Pharmacies for the Treatment of Acute Pain

TIVORBEX Now Available in U.S. Pharmacies for the Treatment of Acute Pain TIVORBEX Now Available in U.S. Pharmacies for the Treatment of Acute Pain Second Low-Dose SoluMatrix NSAID from Iroko Now Available by Prescription PHILADELPHIA, June 29, 2015 Iroko Pharmaceuticals, LLC,

More information

Salicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 &

Salicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 & DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS Chapters 17, 18, 34 & Pages 577 & 579-586 Salicylates aspirin Have analgesic, antipyretic, and anti-inflammatory effects. Inhibits the production

More information

Ibuprofen. Ibuprofen and Paracetamol: prescribing overview. Ibuprofen indications CYCLO-OXYGENASE (COX I) CYCLO-OXEGENASE (COX II) INFLAMMATORY PAIN

Ibuprofen. Ibuprofen and Paracetamol: prescribing overview. Ibuprofen indications CYCLO-OXYGENASE (COX I) CYCLO-OXEGENASE (COX II) INFLAMMATORY PAIN Ibuprofen Ibuprofen and Paracetamol: prescribing overview Sarah Holloway Macmillan CNS in palliative care NSAID Non-selective COX inhibitor Oral bioavailability: 90% Onset of action: 20-30 mins (can take

More information

Pain: A Public Health Challenge. NSAIDS for Managing Pain. Iroko: Innovators in Analgesia

Pain: A Public Health Challenge. NSAIDS for Managing Pain. Iroko: Innovators in Analgesia Pain: A Public Health Challenge Despite advances in understanding and treatment, pain remains a major public health challenge 1 that exacts a significant personal and economic toll on Americans. 1 Pain

More information

NSAIDS - non-salicylates

NSAIDS - non-salicylates NSAIDS - non-salicylates Sandra P. Welch, Ph.D. Professor Pharmacology & Toxicology McGuire Hall Room 505, 828-8424, swelch@hsc.vcu.edu Learning Objectives: 1. Learn the main differentiating property,

More information

LOW DOSE ASPIRIN CARDIOVASCULAR DISEASE FOR PROPHYLAXIS OF FOR BACKGROUND USE ONLY NOT TO BE USED IN DETAILING

LOW DOSE ASPIRIN CARDIOVASCULAR DISEASE FOR PROPHYLAXIS OF FOR BACKGROUND USE ONLY NOT TO BE USED IN DETAILING LOW DOSE ASPIRIN FOR PROPHYLAXIS OF CARDIOVASCULAR DISEASE FOR BACKGROUND USE ONLY NOT TO BE USED IN DETAILING Use of Low Dose Aspirin to Treat and Prevent Cardiovascular Disease In recent decades, aspirin

More information

Today, these are all common knowledge, especially in this wonderful age of the Internet, where Dr. Google is on-call 24/7.

Today, these are all common knowledge, especially in this wonderful age of the Internet, where Dr. Google is on-call 24/7. MY column on Aspirin, the Wonder Drug came out in 2002 when this common household item was on the spotlight for sometime for its new role in staving off heart attack, medically termed Acute Myocardial

More information

Rimoxen. Rimoxen! "The Gastro and Cardio friendly anti-inflammatory ingredient"

Rimoxen. Rimoxen! The Gastro and Cardio friendly anti-inflammatory ingredient Rimoxen A Botanical Anti-Inflammatory COX-2 Selective Ingredient Question: How doses Rimoxen compare to the prescription COX-2 inhibitors (Vioxx and Celebrex) and the OTC NSAID pain relievers such as aspirin

More information

NSAIDs Overview. Souraya Domiati, Pharm D, MS

NSAIDs Overview. Souraya Domiati, Pharm D, MS NSAIDs Overview Souraya Domiati, Pharm D, MS Case A 32 years old shows up into your pharmacy asking for an NSAID for his ankle pain He smokes1 pack/day His BP is 125/75mmHg His BMI is 35kg/m2 His is on

More information

Counselling on non-steroidal anti-inflammatory drugs By Megan Deldot and Associate Professor Lisa Nissen

Counselling on non-steroidal anti-inflammatory drugs By Megan Deldot and Associate Professor Lisa Nissen Counselling on non-steroidal anti-inflammatory drugs By Megan Deldot and Associate Professor Lisa Nissen A 72-year-old man, Mr BK, presents to the pharmacy requesting Voltaren Rapid for his bad arthritis.

More information

5 MUSCULOSKELETAL SYSTEM

5 MUSCULOSKELETAL SYSTEM 5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every

More information

Drug Therapy Today in Rheumatic Diseases

Drug Therapy Today in Rheumatic Diseases Drug Therapy Today in Rheumatic Diseases Piotr Leszczynski,, MD, PhD,, CCD A wide range of drugs are currently avaiable for rheumatic diseases Analgesic drugs (acetaminophen, opioids) NSAIDs (analgesic

More information

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain.

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. Pharmacology - Problem Drill 19: Anti-Inflammatory and Analgesic Drugs No. 1 of 10 1. are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. #01 (A) Nociceptors (B) Histamines

More information

disease or in clients who consume alcohol on a regular basis. bilirubin

disease or in clients who consume alcohol on a regular basis. bilirubin NON-OPIOID Acetaminophen(Tylenol) Therapeutic class: Analgesic, antipyretic Aspirin (ASA, Acetylsalicylic Acid) Analgesic, NSAID, antipyretic Non-Opioid Analgesics COMMON USES WHAT I NEED TO KNOW AS A

More information

Pain therapeutics. Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain

Pain therapeutics. Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain Pain therapeutics Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain James McCormack, Pharm.D. Professor Faculty of Pharmaceutical Sciences, UBC Common types of pain killers

More information

Available Strengths. Cost per Rx 325 mg tablet - $ mg tablet - $ mg ER tablet - $ mg capsule - $ mg chewable tablet

Available Strengths. Cost per Rx 325 mg tablet - $ mg tablet - $ mg ER tablet - $ mg capsule - $ mg chewable tablet MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Non-Opioids LAST REVIEW 5/9/2017 THERAPEUTIC CLASS Pain REVIEW HISTORY 2/16, 5/15 LOB AFFECTED Medi-Cal (MONTH/YEAR) This

More information

Pain: A Public Health Challenge. NSAIDS for Managing Pain. Iroko: Innovators in Analgesia

Pain: A Public Health Challenge. NSAIDS for Managing Pain. Iroko: Innovators in Analgesia Pain: A Public Health Challenge Despite advances in understanding and treatment, pain remains a major public health challenge 1 that exacts a significant personal and economic toll on Americans 2. Pain

More information

Accounting for cardiovascular risk when prescribing NSAIDs

Accounting for cardiovascular risk when prescribing NSAIDs MEDICINES OPTIMISATION Accounting for cardiovascular risk when prescribing NSAIDs DAVID LAIGHT It is now recognised that oral NSAIDs can increase the risk of cardiovascular events, including myocardial

More information

Balanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D

Balanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D Balanced Analgesia With NSAIDS and Coxibs Raymond S. Sinatra MD, Ph.D Prostaglandins and Pain The primary noxious mediator released from damaged tissue is prostaglandin (PG) PG is responsible for nociceptor

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 38 Effective Health Care Program Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review Executive Summary Background Osteoarthritis

More information

NSAID, antirheumatics, antipyretics

NSAID, antirheumatics, antipyretics NSAID, antirheumatics, antipyretics Doc. PharmDr. Jan Juřica, Ph.D. Mgr. Barbora Ondráčková MUDr. Jana Nováková, Ph.D. PharmDr. Jana Rudá-Kučerová, Ph.D. MVDr. Leoš Landa, Ph.D. Notes for Pharmacology

More information

Chapter 36 Nonsteroidal Anti-Inflammatory Drugs

Chapter 36 Nonsteroidal Anti-Inflammatory Drugs Chapter 36 Nonsteroidal Anti-Inflammatory Drugs THERAPEUTIC STRATEGIES The treatment of patients with inflammation involves two primary goals: To relieve pain, To slow or arrest the tissue damaging process.

More information

This document has not been circulated to either the industry or Consultants within the Suffolk system.

This document has not been circulated to either the industry or Consultants within the Suffolk system. New Medicine Report Document Status COX II Inhibitors In Acute Analgesia For Suffolk Drug & Therapeutics Committee Date of Last Revision 15 th February 2002 Reviewer s Comments There seems to be a growing

More information

Iroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX snda for the Treatment of Osteoarthritis Pain in Adults

Iroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX snda for the Treatment of Osteoarthritis Pain in Adults Iroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX snda for the Treatment of Osteoarthritis Pain in Adults First Lower Dose NSAID Using SoluMatrix Fine Particle Technology to be Reviewed

More information

Hurts So Good! The Concept of Pain and Pain Management. The Concept of Pain. The Concept of Pain. Program Learning Objectives

Hurts So Good! The Concept of Pain and Pain Management. The Concept of Pain. The Concept of Pain. Program Learning Objectives Program Learning Objectives Hurts So Good! Management of Dental Pain and Patient Care Considerations Thomas A. Viola, R.Ph., C.C.P. Fourth District Dental Society May 22, 2015 2015 Thomas A. Viola, R.Ph.

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Celebrex) Reference Number: CP.CPA.239 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy

More information

Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor

Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor DRUG EVALUATION Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor Alejandro Escudero- Contreras, Janitzia Vazquez-Mellado Cervantes & Eduardo Collantes-Estevez Author

More information

Dr Nataraj H R. Lecturer Post graduate Department Dravyaguna

Dr Nataraj H R. Lecturer Post graduate Department Dravyaguna By Dr Nataraj H R Lecturer Post graduate Department Dravyaguna Introduction Prostaglandins are the most distributed autocoids in the body Prostaglandins are biological active derivatives of 20 carbon atom

More information

j371 Index Acetylsalicylic Acid. Karsten Schrör Copyright Ó 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim ISBN:

j371 Index Acetylsalicylic Acid. Karsten Schrör Copyright Ó 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim ISBN: j371 Index a Aberrant crypt foci (ACF) 343 ACE inhibitors 184, 246, 249, 252 Acetaminophen (Paracetamol) Alzheimers disease 361f. analgesic action 324ff. analgesic nephropathy 180, 182 asthma 197ff., 217ff.

More information

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet COLCRYS-PST Mitigare 0.6 mg capsule Colcrys 0.6 mg tablet Criteria If the patient has tried one Step 1 product, authorization for a Step 2 product may be given. Exceptions can be made for a step 2 drug

More information

- Mohammad Sinnokrot. -Ensherah Mokheemer. - Malik Al-Zohlof. 1 P a g e

- Mohammad Sinnokrot. -Ensherah Mokheemer. - Malik Al-Zohlof. 1 P a g e -1 - Mohammad Sinnokrot -Ensherah Mokheemer - Malik Al-Zohlof 1 P a g e Introduction Two of the most important problems you will face as a doctor are coagulation and bleeding, normally they are in balance,

More information

Nonopioid Analgesics

Nonopioid Analgesics Med Clin N Am 91 (2007) 97 111 Nonopioid Analgesics Muhammad A. Munir, MD*, Nasr Enany, MD, Jun-Ming Zhang, MSc, MD Department of Anesthesiology, University of Cincinnati College of Medicine, 231 Albert

More information

2018 WPS MedicareRx Plan (PDP) Step Therapy

2018 WPS MedicareRx Plan (PDP) Step Therapy 2018 WPS MedicareRx Plan (PDP) Step Therapy In some cases, the WPS MedicareRx Plan (PDP) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

OBJECTIVE. Lipids are largely hydrocarbon derivatives and thus represent

OBJECTIVE. Lipids are largely hydrocarbon derivatives and thus represent Paper 4. Biomolecules and their interactions Module 20: Saturated and unsaturated fatty acids, Nomenclature of fatty acids and Essential and non-essential fatty acids OBJECTIVE The main aim of this module

More information

Acetaminophen. TIP Session IV

Acetaminophen. TIP Session IV Acetaminophen TIP Session IV History Acetaminophen (paracetamol) was introduced in 1893 but remained unpopular for more than 50 years, until it was observed that it is a metabolite of both acetanilide

More information

Drug Use Criteria: Cyclooxygenase-2 Inhibitors

Drug Use Criteria: Cyclooxygenase-2 Inhibitors Texas Vendor Program Use Criteria: Cyclooxygenase-2 Inhibitors Publication History Developed January 2002. Revised May 2016; October 2014; February 2013; December 2012; March 2011; January 2011; October

More information

Iroko Pharmaceuticals Gains Additional Patents for ZORVOLEX and TIVORBEX TM

Iroko Pharmaceuticals Gains Additional Patents for ZORVOLEX and TIVORBEX TM Iroko Pharmaceuticals Gains Additional Patents for ZORVOLEX and TIVORBEX TM PHILADELPHIA, April 8, 2015 Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the

More information

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN BURANA 40 MG/ML ORAL SUSPENSION DATE: , VERSION 1

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN BURANA 40 MG/ML ORAL SUSPENSION DATE: , VERSION 1 PUBLIC SUMMARY OF RISK MANAGEMENT PLAN BURANA 40 MG/ML ORAL SUSPENSION DATE: 15-5-2015, VERSION 1 VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Musculoskeletal pain: Musculoskeletal

More information

Name Brufen Flu Tablets & Suspension Description For the relief of the symptoms of colds and flu. Active Ingredients:

Name Brufen Flu Tablets & Suspension Description For the relief of the symptoms of colds and flu. Active Ingredients: Name Brufen Flu Tablets & Suspension Description For the relief of the symptoms of colds and flu Active Ingredients: Brufen Flu each tablet (Film-coated) contains: Ibuprofen 200 mg Pseudoephedrine hydrochloride

More information

PRODUCT INFORMATION. Sudafed* Sinus + Anti-inflammatory Pain Relief Caplets

PRODUCT INFORMATION. Sudafed* Sinus + Anti-inflammatory Pain Relief Caplets PRODUCT INFORMATION Sudafed* Sinus + Anti-inflammatory Pain Relief Caplets Product description Sudafed* Sinus + Anti-inflammatory Pain Relief caplets contain pseudoephedrine hydrochloride 30 mg and ibuprofen

More information

ASPIRIN AND VASCULAR DISEASE

ASPIRIN AND VASCULAR DISEASE ASPIRIN AND VASCULAR DISEASE SUMMARY Aspirin is an effective antiplatelet agent for patients with cardiovascular and cerebrovascular disease. Incidence of adverse effects and drug interactions increases

More information

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet COLCRYS-PST Mitigare 0.6 mg capsule Colcrys 0.6 mg tablet Criteria If the patient has tried one Step 1 product, authorization for a Step 2 product may be given. Exceptions can be made for a step 2 drug

More information

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for

More information

PRODUCT INFORMATION FELDENE GEL

PRODUCT INFORMATION FELDENE GEL PRODUCT INFORMATION FELDENE GEL (piroxicam) NAME OF THE MEDICINE Feldene Gel contains the active component piroxicam (anhydrous), a nonsteroidal antiinflammatory agent of the chemical class N-heterocyclic

More information

MESULID 100 REVISED PRODUCT INFORMATION

MESULID 100 REVISED PRODUCT INFORMATION MESULID 100 REVISED PRODUCT INFORMATION COMPOSITION Each caplet of MESULID 100 contains: Nimesulide 100 mg. Inactive Ingredients Lactose, microcrystalline cellulose, sodium starch glycolate, hydrogenated

More information

Action Rufenal contains a non - steroidal compound with pronounced antirheumatic, anti-inflammatory, analgesic and antipyretic properties.

Action Rufenal contains a non - steroidal compound with pronounced antirheumatic, anti-inflammatory, analgesic and antipyretic properties. RUFENAL Composition Rufenal Injection Each ampoule of 3 ml contains Diclofenac sodium 75 mg. Ampoule, Tablets & Suppositories Rufenal 12.5 Suppositories Each suppository contains Diclofenac sodium 12.5

More information

SALICYLATES (ASPIRIN)

SALICYLATES (ASPIRIN) Dr. Green ANTI-INFLAMMATORY DRUGS Many categories of drugs will be discussed. 1. Non-narcotic analgesics/nonsteroidal Anti-inflammatory drugs (NSAIDs). Some compounds are used for analgesic action at low

More information

Managing Musculoskeletal Pain and Injury

Managing Musculoskeletal Pain and Injury Managing Musculoskeletal Pain and Injury New & Old Drugs: Best Choices MAY 5, 2017 WILLIAM KNOPP, MD Dr. Knopp indicated no potential conflict of interest to this presentation. He does not intend to discuss

More information

ANSC/NUTR 618 Lipids & Lipid Metabolism

ANSC/NUTR 618 Lipids & Lipid Metabolism I. Nonessential fatty acids ANSC/NUTR 618 Lipids & Lipid Metabolism A. Synthesized completely by the fatty acid synthase reaction (e.g., myristic and palmitic acid). B. Produced by the modification of

More information

Anti-inflammatory. * normal, protective, response to tissue injury caused by physical trauma, noxious chemicals, microbiologic agents.

Anti-inflammatory. * normal, protective, response to tissue injury caused by physical trauma, noxious chemicals, microbiologic agents. Anti-inflammatory Over view: inflammatory : * normal, protective, response to tissue injury caused by physical trauma, noxious chemicals, microbiologic agents. * the body effort to inactive or destroy

More information

INFLAMMATION & REPAIR

INFLAMMATION & REPAIR INFLAMMATION & REPAIR Lecture 7 Chemical Mediators of Inflammation Winter 2013 Chelsea Martin Special thanks to Drs. Hanna and Forzan Course Outline i. Inflammation: Introduction and generalities (lecture

More information

Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs

Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs Carlo Patrono, 1 Paola Patrignani, 1 and Luis A. García Rodríguez 2 1 Department

More information

Drug Use Criteria: Oral Ketorolac/Intranasal Ketorolac (Sprix )

Drug Use Criteria: Oral Ketorolac/Intranasal Ketorolac (Sprix ) Texas Vendor Program Use Criteria: Oral Ketorolac/Intranasal Ketorolac (Sprix ) Publication History 1. Developed February 1995. 2. Revised May 2016; December 2014; March 2013; May 2011; January 2009; October

More information

Etodolac versus meloxicam

Etodolac versus meloxicam Etodolac versus meloxicam The Borg System is 100 % Etodolac versus meloxicam Etodolac versus meloxicam -- 722 75051 1991 Wainwright Not Specific Enough. The store also now says majority of Irish willing

More information

Therapeutic Agents for the Musculoskeletal System

Therapeutic Agents for the Musculoskeletal System 1 Therapeutic Agents for the Musculoskeletal System Chapter 17 1 Anatomy and Physiology of the Skeletal System Provides structural support for the body Consists of muscles, tendons, ligaments, and bones

More information

Helpline No:

Helpline No: ARTHRITIS FOUNDATION Registered Nonprofit Organisation - No. 002-847 NPO Helpline No: 0861 30 30 30 DRUGS AND ARTHRITIS This information leaflet is published by the Arthritis Foundation as part of our

More information

In 1971, Sir John Vane proposed that nonsteroidal

In 1971, Sir John Vane proposed that nonsteroidal Non-steroidal antiinflammatory drugs: facts and fallacies This article serves to review NSAIDs, their mechanism of action and adverse effects, as well as to establish the therapeutic position of the new-generation

More information

- To reduce the risk of myocardial infarction in patients with unstable angina or in patients who have had a previous myocardial infarction.

- To reduce the risk of myocardial infarction in patients with unstable angina or in patients who have had a previous myocardial infarction. SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM: BAYER ASPIRIN Cardio 100 Enteric Coated Tablets COMPOSITION: The active ingredient is 100mg Acetylsalicylic acid per tablet. Excipients are: cellulose,

More information

COX-2 inhibitors: A cautionary tale. October 2, 2006

COX-2 inhibitors: A cautionary tale. October 2, 2006 COX-2 inhibitors: A cautionary tale October 2, 2006 Molecular interventions in human disease... An approach as old as human civilization. With whom the herbs have come together Like kingly chiefs unto

More information

RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: , VERSION 1.

RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: , VERSION 1. RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: 07-10-2016, VERSION 1.2 VI.2 Elements for a Public Summary Etoricoxib Orion

More information

APO-CELECOXIB CAPSULES. 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide

APO-CELECOXIB CAPSULES. 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide APO-CELECOXIB CAPSULES NAME OF THE MEDICINE Celecoxib Chemical Name: 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Structural Formula: Molecular Formula: C17H14F3N3O2S Molecular

More information

PAIN MANAGEMENT IN HIP SURGERY. Khoa D. Nguyen, MD, PhD Dept. of Rheumatology, Cho Ray Hosital

PAIN MANAGEMENT IN HIP SURGERY. Khoa D. Nguyen, MD, PhD Dept. of Rheumatology, Cho Ray Hosital PAIN MANAGEMENT IN HIP SURGERY Khoa D. Nguyen, MD, PhD Dept. of Rheumatology, Cho Ray Hosital MUSCULOSKELETAL PAIN IS COMMON Hip replacement increasing POSTOPERATIVE PAIN: INTRODUCTION Very common Causes

More information

Asprin Bryce Gates Richard hammond Agustin chavez

Asprin Bryce Gates Richard hammond Agustin chavez Asprin Bryce Gates Richard hammond Agustin chavez Who discovered asprins? The discovery of aspirin is customarily said to have resulted from Felix Hoffmann's rheumatic father encouraging his son to produce

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET IBUPROFEN (Arrowcare) Ibuprofen Tablets 200mg Presentation NEW ZEALAND DATA SHEET White, capsule shaped, coated tablets with no markings. Uses Actions Ibuprofen is a non-steroidal anti-inflammatory agent.

More information

Public Assessment Report Scientific discussion. Aspirin (acetylsalicylic acid) Asp no:

Public Assessment Report Scientific discussion. Aspirin (acetylsalicylic acid) Asp no: Public Assessment Report Scientific discussion Aspirin (acetylsalicylic acid) Asp no: 2015-0454 This module reflects the scientific discussion for the approval of Aspirin. The procedure was finalised on

More information

NSAID Regional Audit Group Presentation. Audit Group: Dr Richard Latten, Ruth Clark, Dr Sarah Fradsham, Dr Seamus Coyle, Claire Johnston

NSAID Regional Audit Group Presentation. Audit Group: Dr Richard Latten, Ruth Clark, Dr Sarah Fradsham, Dr Seamus Coyle, Claire Johnston NSAID Regional Audit Group Presentation Audit Group: Dr Richard Latten, Ruth Clark, Dr Sarah Fradsham, Dr Seamus Coyle, Claire Johnston Thank you from the audit group for all who participated in the data

More information